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Background
Management of co-infection with malaria and HIV is a
major challenge to public health and yet potential drug-
drug interactions between antimalarial and antiviral regi-
mens have not been adequately investigated in people
with both infections. Both of the constituent components
of artemether-lumefantrine (AL) the first-line regimen for
malaria treatment in Nigeria, and nevirapine, a major
component of highly active antiretroviral therapy, are
drugs metabolised by the cytochrome P450 3A4 isoen-
zyme system, known to be induced by nevirapine. We
examined potential interactions between lumefantrine and
nevirapine in 68 HIV-positive and 99 HIV-negative adults,
all of whom were diagnosed with asymptomatic Plasmo-
dium falciparum infections by microscopy. Post hoc PCR
analysis confirmed the presence of P. falciparum in only a
minority of participants.
Materials and methods
68 out of 80 attendees at the HIV clinics tested were iden-
tified as positive for P. falciparum and returned for day 7
follow-up (85%). None of these individuals reported
concurrent symptoms suggestive of clinical malaria. 126
additional volunteers agreed to have a rapid HIV test per-
formed, of which 99 were found to be both negative for
HIV and infected with P. falciparum. None of these indivi-
duals were symptomatic. All 167 participants were treated
with a full adult course of AL, and followed up on days 3,
7 and 28 for repeat blood sampling. We recorded and
examined the distribution of lumefantrine concentration at
day 7 in all study participants.
Results
Using the PCR data as a more reliable test for parasite car-
riage, we found weak evidence that HIV positive people
were more likely to be parasitaemic at day 0 (OR 2.05,
95% C.I. 0.917 - 4.60; P = 0.054), which may reflect slightly
higher parasite densities in this group. HIV-positive sub-
jects were not significantly more likely to be PCR positive
for P. falciparum at day 3 and/or day 28 after AL treat-
ment than were HIV negative individuals (OR 1.75, 95%
C.I. 0.776 - 3.95; P = 0.141).
HIV status, and thus nevirapine use, was found to have a
significant effect on the concentration of lumefantrine 7
days after treatment (Wilcoxon ranksum test z = -3.270,
P=0.0011), with a median concentration in the HIV nega-
tive group of 2.75µM (IQR 1.03 - 4.31), and in the HIV
positive group of 3.55µM (IQR 2.07 - 5.37. There was a
significant association between HIV status and lumefan-
trine concentration at 7 days post AL treatment (z =
-2.830, P=0.0046). Day 7 capillary blood levels of lumefan-
trine were significantly higher in nevirapine-treated HIV
positive participants than in 99 HIV negative controls
(P=0.0011). Higher day 7 levels of lumefantrine were not
associated with lower risk of persistent PCR-detectable
parasitaemia at day 3 post-treatment.
Conclusion
Nevirapine increases peripheral lumefantinre levels in
AL-treated adult African malaria patients. Preliminary
data suggest that higher lumefantrine concentrations do
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not provide any parasitological benefit to nevirapine-
treated HIV patients.
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